{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T03:08:40Z","timestamp":1777000120462,"version":"3.51.4"},"reference-count":77,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100004326","name":"Bayer AG","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Ther Adv Respir Dis"],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:p> Riociguat is one of several approved therapies available for patients with pulmonary arterial hypertension (PAH). Treatment should be initiated and monitored at an expert center by a physician experienced in treating PAH, and the dose adjusted in the absence of signs and symptoms of hypotension. In certain populations, including patients with hepatic or renal impairment, the elderly, and smokers, riociguat exposure may differ, and dose adjustments should therefore be made with caution according to the established scheme. Common adverse events are often easily managed, particularly if they are discussed before starting therapy. Combination therapy with riociguat and other PAH-targeted agents is feasible and generally well tolerated, although the coadministration of phosphodiesterase type\u20095 inhibitors (PDE5i) and riociguat is contraindicated. An open-label, randomized study is currently ongoing to assess whether patients who do not achieve treatment goals while receiving PDE5i may benefit from switching to riociguat. In this review, we provide a clinical view on the practical management of patients with PAH receiving riociguat, with a focus on the opinions and personal experience of the authors. <\/jats:p><jats:p> The reviews of this paper are available via the supplemental material section. <\/jats:p>","DOI":"10.1177\/1753466619868938","type":"journal-article","created":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T06:06:05Z","timestamp":1566540365000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":10,"title":["Practical management of riociguat in patients with pulmonary arterial hypertension"],"prefix":"10.1177","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9184-4799","authenticated-orcid":false,"given":"Michael","family":"Halank","sequence":"first","affiliation":[{"name":"Internal Clinical I, University Hospital Carl Gustav Carus, Fetscherstrasse 74, Dresden, 01307, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin","family":"Tausche","sequence":"additional","affiliation":[{"name":"Medical Clinic 1\/Pneumology, University Hospital Carl Gustav Carus, Dresden, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekkehard","family":"Gr\u00fcnig","sequence":"additional","affiliation":[{"name":"Center for Pulmonary Hypertension, Thorax Clinic at University Hospital, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Ewert","sequence":"additional","affiliation":[{"name":"Clinic for Internal Medicine B, Ernst-Moritz-Arndt-University Greifswald, Greifswald, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioana R.","family":"Preston","sequence":"additional","affiliation":[{"name":"Pulmonary, Critical Care and Sleep Division, Tufts University Medical Center, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2019,8,22]]},"reference":[{"key":"bibr1-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1183\/09059180.00006613"},{"key":"bibr2-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2011.87"},{"key":"bibr3-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1378\/chest.14-0793"},{"key":"bibr4-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.10.025"},{"key":"bibr5-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01032-2015"},{"key":"bibr6-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0063-2015"},{"key":"bibr7-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00740-2017"},{"key":"bibr8-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01913-2018"},{"key":"bibr9-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2015-207170"},{"key":"bibr10-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-540-68964-5_13"},{"key":"bibr11-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.981738"},{"key":"bibr12-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-662-45805-1_12"},{"key":"bibr13-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1002\/anie.201302588"},{"key":"bibr14-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2016.05.024"},{"key":"bibr15-1753466619868938","doi-asserted-by":"crossref","first-page":"15","DOI":"10.17352\/gjrd.000009","volume":"2","author":"Benza RL","year":"2017","journal-title":"J Rare Dis"},{"key":"bibr16-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2018.08.084"},{"key":"bibr17-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1209655"},{"key":"bibr18-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1209657"},{"key":"bibr19-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(16)30022-4"},{"key":"bibr20-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00090614"},{"key":"bibr21-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(16)30019-4"},{"key":"bibr22-1753466619868938","first-page":"A4777","volume":"191","author":"Mathai SC","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"bibr23-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2014.12.001"},{"key":"bibr24-1753466619868938","first-page":"A7329","volume":"193","author":"Rosenzweig EB","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"bibr25-1753466619868938","first-page":"PA2401","volume":"48","author":"Humbert M","year":"2016","journal-title":"Eur Resp J"},{"key":"bibr26-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2017.11.006"},{"key":"bibr27-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02004-2018"},{"key":"bibr28-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01904-2018"},{"key":"bibr29-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1177\/2045894018759246"},{"key":"bibr30-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1086\/685020"},{"key":"bibr31-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1086\/685018"},{"key":"bibr32-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2017.05.005"},{"key":"bibr33-1753466619868938","unstructured":"Bayer AG. Adempas (riociguat tablets): EU summary of product characteristics 2018, http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/002737\/WC500165034.pdf (accessed November 11, 2018)."},{"key":"bibr34-1753466619868938","unstructured":"Bayer AG. Adempas, US prescribing information 2018, http:\/\/labeling.bayerhealthcare.com\/html\/products\/pi\/Adempas_PI.pdf (accessed November 11, 2018)."},{"key":"bibr35-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1086\/682228"},{"key":"bibr36-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-017-0604-7"},{"key":"bibr37-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1086\/685428"},{"key":"bibr38-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00105914"},{"key":"bibr39-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1086\/685016"},{"key":"bibr40-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2018.PA3036"},{"key":"bibr41-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1177\/0091270010378119"},{"key":"bibr42-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1086\/685014"},{"key":"bibr43-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1159\/000470916"},{"key":"bibr44-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-018-0100-3"},{"key":"bibr45-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.018435"},{"key":"bibr46-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.004526"},{"key":"bibr47-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1086\/685017"},{"key":"bibr48-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1086\/685015"},{"key":"bibr49-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1086\/685647"},{"key":"bibr50-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1177\/2045894018769305"},{"key":"bibr51-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-209087"},{"key":"bibr52-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2016.1248400"},{"key":"bibr53-1753466619868938","unstructured":"Hoeper MM, Gall H, Gr\u00fcnig Eet al Safety of riociguat for the treatment of pulmonary arterial hypertension: final data cut from the EXPERT registry. In: ATS Dallas, TX, USA, 17th - 22nd May, 2019."},{"key":"bibr54-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1007\/s41030-017-0029-3"},{"key":"bibr55-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2018.01.115"},{"key":"bibr56-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1177\/2045894019826944"},{"key":"bibr57-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02425-2016"},{"key":"bibr58-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlc.2019.01.013"},{"key":"bibr59-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-018-0160-4"},{"key":"bibr60-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1177\/2045893217708566"},{"key":"bibr61-1753466619868938","first-page":"A2282","volume":"195","author":"Weir N","year":"2017","journal-title":"ATS"},{"key":"bibr62-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2018.08.082"},{"key":"bibr63-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx257"},{"key":"bibr64-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00889-2017"},{"key":"bibr65-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-0676"},{"key":"bibr66-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2019.02.004"},{"key":"bibr67-1753466619868938","unstructured":"Humbert M, Farber HW, Ghofrani HAet al Riociguat in pulmonary arterial hypertension (PAH): evaluation of abbreviated versions of the ESC\/ERS risk assessment tool in PATENT-2. In: ATS 2018 San Diego, CA, USA, 18th\u201323rd May, 2018."},{"key":"bibr68-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1177\/1479972318787906"},{"key":"bibr69-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-6-92"},{"key":"bibr70-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199602013340504"},{"key":"bibr71-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020204"},{"key":"bibr72-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.165.6.2106079"},{"key":"bibr73-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.04.050"},{"key":"bibr74-1753466619868938","first-page":"P3419","volume":"42","author":"Ghofrani HA","year":"2013","journal-title":"Euro Respir J"},{"key":"bibr75-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0078-2016"},{"key":"bibr76-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2014.0452"},{"key":"bibr77-1753466619868938","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2012.1133"}],"container-title":["Therapeutic Advances in Respiratory Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1753466619868938","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1753466619868938","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1753466619868938","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T02:53:46Z","timestamp":1741056826000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1753466619868938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":77,"alternative-id":["10.1177\/1753466619868938"],"URL":"https:\/\/doi.org\/10.1177\/1753466619868938","relation":{},"ISSN":["1753-4666","1753-4666"],"issn-type":[{"value":"1753-4666","type":"print"},{"value":"1753-4666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1]]},"article-number":"1753466619868938"}}